To verify that hyperglycemia-dependent increases in ISF Aβ were Kir6.2 dependent, we explored whether inhibition of Kir6.1-containing KATP channels, which are predominantly localized to the vasculature, could directly modulate ISF Aβ levels. The gene discussed is KCNJ11; the disease is Hyperglycemia.